CollPlant Biotechnologies (CLGN) Interest Coverage Ratio (2017 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Interest Coverage Ratio came in at 0.11 in Q4 2025, up 97.97% YoY from 0.06 in Q4 2024, and up 97.97% on a QoQ basis from 5.37 in Q4 2024.
CollPlant Biotechnologies (CLGN) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 9 years of Interest Coverage Ratio data on file, last reported at 0.11 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 97.97% year-over-year to 0.11 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.18 (down 162.84% YoY) and the FY2025 annual result came in at 0.4, up 47.44% from the prior year.
- Interest Coverage Ratio grew to 0.11 in Q4 2025, from 5.37 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 382.88 in Q2 2021 to a low of 527.68 in Q1 2021.
- A 5-year average of 8.11 and a median of 6.43 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio slumped 223.65% — and 2023, when it surged 54209.73%.
- Tracing CLGN's Interest Coverage Ratio over 5 years: stood at 0.11 in 2021, then sank by 95.34% to 0.21 in 2022, then surged by 54209.73% to 112.62 in 2023, then sank by 104.77% to 5.37 in 2024, then surged by 97.97% to 0.11 in 2025.
- The last three Interest Coverage Ratio figures came in at 0.11 (Q4 2025), 5.37 (Q4 2024), and 98.74 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 1.42 |
| 10 | CollPlant Biotechnologies | 4.33 Mn | 4.33 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11 |
| Dec 31, 2024 | -5.37 |
| Sep 30, 2024 | 98.74 |
| Jun 30, 2024 | 13.15 |
| Mar 31, 2024 | 34.63 |
| Dec 31, 2023 | 112.62 |
| Sep 30, 2023 | -40.73 |
| Jun 30, 2023 | 32.82 |
| Mar 31, 2023 | 12.48 |
| Dec 31, 2022 | -0.21 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | 0.39 |
| Jun 30, 2021 | 382.88 |
| Mar 31, 2021 | -527.68 |
| Dec 31, 2020 | -0.70 |
| Sep 30, 2020 | -66.73 |
| Jun 30, 2020 | -956.50 |
| Mar 31, 2020 | 426.75 |
| Dec 31, 2019 | -1.91 |
| Sep 30, 2019 | 1.26 |